Shan Yuan, M.D.
- Associate Clinical Professor of Pathology
Shan Yuan, M.D.
- Transfusion Medicine
Areas of Expertise
- Transfusion Medicine
Other Languages Spoken
Shan Yuan, M.D., is a key member of the team that ensures that each blood transfusion at City of Hope is conducted safely and effectively.
A multiple honors student dating back to her college days, Dr. Yuan received her medical degree from Duke University in Durham, North Carolina and continued her training at the University of Washington Medical Center in Seattle.
Dr. Yuan has served as City of Hope's assistant medical director of transfusion medicine since 2012, following a five-year term in similar capacity at UCLA's David Geffen School of Medicine. She is a sought-after lecturer and prolific publisher on all aspects of transfusion and stem cell transplants.
- 2012 - present, Associate Clinical Professor, Department of Pathology, City of Hope, Duarte, CA
- 2007 - 2012, Associate Medical Director of Transfusion Medicine, Assistant Professor, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
- 2005 - 2007, Staff Physician, Transfusion Medicine, City of Hope, Duarte, CA
- 1996-2000, Doctor of Medicine, Duke University School of Medicine, Durham, NC
- 1992 –1996, Bachelor of Arts, Biology, Oberlin College, Oberlin, OH
- 2004 –2005, Fellow, Transfusion Medicine, Puget Sound Blood Center and University of Washington Medical Center, Seattle, WA
- 2000 –2004, Chief Resident, Laboratory Medicine (2003-2004), Resident, Anatomic Pathology and Laboratory Medicine, University of Washington Medical Center, Seattle, WA
- American Board of Pathology, Blood Banking/Transfusion Medicine
- American Board of Pathology, Clinical Pathology
- Unrestricted Medical License, State of California
- United States Medical Licensing Examination
- Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor Hematol Oncol. 2017:35:281-287.
- Salhotra A, Yuan S, Tsai NC, Sanchez JF, Aldoss I, Ali H, Paris T, Spielberger R, Cao TM, Nademanee A, Forman ST, Chen R. Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure Despite Plerixafor Rescue. Biology of Blood and Marrow Transplantation 2017; 23:1264-1268.
- Yuan S, Chang S, Uyeno K, Almquist G, Wang S. Blood donation mobile applications: Are donors ready? Transfusion. 2016; 56:614-621.
- Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor Hematol Oncol. 2016 Feb 29;2016 DOI: 10.1002/hon.2286. [Epub ahead of print]
- Finck RH, Ziman A, Hoffman M, Phan-Tang M, Yuan S. Motivating factors and potential deterrents to blood donation in high school aged blood donors. Accepted for publication by Journal of Blood Transfusion 2016;2016:8624230. DOI: 10.1155/2016/8624230. Epublished.
- Yuan S, Wang S. How do we mobilize and collect autologous peripheral blood stem cells. Transfusion 2016; 57:13-23.
- Yuan S, Nademanee A, Kaniewski M, Palmer J, Shayani S, Wang S. Efficacy of Just-in-Time Plerixafor Rescue for Hodgkin Lymphoma Patients with Poor Peripheral Blood Stem Cell Mobilization. Transfusion. 2014;54:2015-2021.
- Yuan S, Wang S, Salhotra A, Nademanee A. Plerixafor to the rescue: Boosting peripheral blood stem cell mobilization in patients previously treated with Hyper-CVAD chemotherapy. Leukemia and Lymphoma. 2014 Jul;55:1557-62
- Yuan S, Nademanee A, Krishnan A, Kogut N, Shayani S, Wang S. Second time the charm? Remobilization of peripheral blood stem cells in patients who had previously mobilized poorly despite using plerixafor as a salvage agent. Transfusion 2013;53: 3244-3250.
- Yuan S, Tsukahara E, De La Cruz K, Kelly R. How we provide transfusion support for pediatric patient on extracorporeal membrane oxygenation (ECMO). Transfusion 2013;53:1157-65.
- Yuan S, Hoffman M, Lu Q, Goldfinger D, Ziman A. Motivating factors and deterrents for blood donation among donors at a university campus-based collection center. Transfusion 2011;51:2435-44.
- Yuan S, Fang A, Davis R, Siplon CJ, Goldfinger D. Immunoglobulin M red blood cell alloantibodies are frequently adsorbed by rabbit erythrocyte stroma. Transfusion 2010;50:1139-43.
- Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger, D. Moderate and severe adverse events associated with blood component donations by apheresis: incidences and risk factors. Transfusion 2010;50:478-86.
- Yuan S, Ziman A, Anthony MA, Tsukahara E, Hopkins C, Lu Q, Goldfinger D. How do we provide transfusion to trauma patients. Transfusion 2009;49:1045-9.
- Yuan S, Davis R, Lu Q, Goldfinger D, Ziman A. Low risk of alloimunization to the Rh(D) antigen in Rh(D-) orthotopic liver transplant recipients receiving Rh(D+) RBCs perioperatively. Transfusion. 2008;48:2653-5.
- Yuan S, Goldfinger D. Editorial: A new assay for anti-IgA: is this what we have been waiting for? Transfusion 2008;48:2048-50.
- American Association of Blood Banks
- California Blood Bank Society
- American Society of Hematology
- 2010-2011, Faramarz Naeim Faculty Teaching Award for Clinical Pathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
- 2004, Paul E. Strandjord Young Investigator Award, 39th Annual Meeting of the Academy of Clinical Physicians and Scientists
- 2003, Strandjord-Clayson Research Award, Department of Laboratory Medicine, University of Washington Medical Center
- 2003, Paul E. Strandjord Young Investigator Award, 38th Annual Meeting of the Academy of Clinical Physicians and Scientists